TY - JOUR
T1 - [In Press] Fabrication and characterization of chitosan nanoparticles using the coffee-ring effect for photodynamic therapy
AU - Bekmukhametova, Alina
AU - Uddin, Mir Muhammad Nasir
AU - Houang, Jessica
AU - Malladi, Chandra
AU - George, Laurel
AU - Wuhrer, Richard
AU - Barman, Shital K.
AU - Wu, Ming J.
AU - Mawad, Damia
AU - Lauto, Antonio
PY - 2022
Y1 - 2022
N2 - Background and Objectives: Biocompatible nanoparticles have been increasingly used in a variety of medical applications, including photodynamic therapy. Although the impact of synthesis parameters and purification methods is reported in previous studies, it is still challenging to produce a reliable protocol for the fabrication, purification, and characterization of nanoparticles in the 200–300 nm range that are highly monodisperse for biomedical applications. Study Design/Materials and Methods: We investigated the synthesis of chitosan nanoparticles in the 200–300 nm range by evaluating the chitosan to sodium tripolyphosphate (TPP) mass ratio and acetic acid concentration of the chitosan solution. Chitosan nanoparticles were also crosslinked to rose bengal and incubated with human breast cancer cells (MCF‐7) to test photodynamic activity using a green laser (λ = 532 nm, power = 90 mW). Results: We established a simple protocol to fabricate and purify biocompatible nanoparticles with the most frequent size occurring between 200 and 300 nm. This was achieved using a chitosan to TPP mass ratio of 5:1 in 1% v/v acetic acid at a pH of 5.5. The protocol involved the formation of nanoparticle coffee rings that showed the particle shape to be spherical in the first approximation. Photodynamic treatment with rose bengal‐nanoparticles killed ~98% of cancer cells. Conclusion: A simple protocol was established to prepare and purify spherical and biocompatible chitosan nanoparticles with a peak size of ~200 nm. These have remarkable antitumor activity when coupled with photodynamic treatment.
AB - Background and Objectives: Biocompatible nanoparticles have been increasingly used in a variety of medical applications, including photodynamic therapy. Although the impact of synthesis parameters and purification methods is reported in previous studies, it is still challenging to produce a reliable protocol for the fabrication, purification, and characterization of nanoparticles in the 200–300 nm range that are highly monodisperse for biomedical applications. Study Design/Materials and Methods: We investigated the synthesis of chitosan nanoparticles in the 200–300 nm range by evaluating the chitosan to sodium tripolyphosphate (TPP) mass ratio and acetic acid concentration of the chitosan solution. Chitosan nanoparticles were also crosslinked to rose bengal and incubated with human breast cancer cells (MCF‐7) to test photodynamic activity using a green laser (λ = 532 nm, power = 90 mW). Results: We established a simple protocol to fabricate and purify biocompatible nanoparticles with the most frequent size occurring between 200 and 300 nm. This was achieved using a chitosan to TPP mass ratio of 5:1 in 1% v/v acetic acid at a pH of 5.5. The protocol involved the formation of nanoparticle coffee rings that showed the particle shape to be spherical in the first approximation. Photodynamic treatment with rose bengal‐nanoparticles killed ~98% of cancer cells. Conclusion: A simple protocol was established to prepare and purify spherical and biocompatible chitosan nanoparticles with a peak size of ~200 nm. These have remarkable antitumor activity when coupled with photodynamic treatment.
UR - https://hdl.handle.net/1959.7/uws:63295
U2 - 10.1002/lsm.23530
DO - 10.1002/lsm.23530
M3 - Article
SN - 0196-8092
JO - Lasers in Surgery and Medicine
JF - Lasers in Surgery and Medicine
ER -